Organigram Global Acquires Aurora Cannabis Inc. at 93% Premium
What happened
Organigram Global announced it will acquire Aurora Cannabis Inc. for C$7.80 per Aurora Common Share. The offer provides Aurora shareholders with the option to receive consideration in cash, Organigram shares, or a combination of both. The offer represents a 93% premium to Aurora’s Unaffected Share Price from August 10, 2026, and a 21% premium to the implied value of the unsolicited Curaleaf Hostile Bid, which was previously rejected by Aurora’s Board of Directors.
From nugget.ca
Why it matters
The combined company will own and operate five EU-GMP certified production and distribution facilities. This transaction is supported by the Boards of Directors of both Organigram Global and Aurora Cannabis Inc., aiming to enhance supply chain certainty and support global market share expansion.
From nugget.ca
Who's involved
- CuraleafThe company whose hostile bid was rejected by Aurora's Board of Directors.
- NasdaqThe American stock exchange where the acquisition involves a listed company.
- board of directorsThe governing body of Aurora Cannabis Inc. that unanimously supported the acquisition.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Organigram global acquisition may change Miguel Martin's role at AuroraMiguel Martin may lose operational control following Organigram Global's acquisition of AuroraLikely
- Acquisition of Aurora by Organigram may increase trading activity on the Toronto Stock ExchangeAcquisition of Aurora by Organigram may increase trading activity on the Toronto Stock Exchange.Possible